Cyclacel Pharmaceuticals, Inc. | 2013 | FY | 3

 

  Year ended
December 31,
2013		  
Preferred shares exchanged     877,869  
Common shares issued:        
At stated convertible option     53,366  
Incremental shares issued under the exchange transaction     1,631,105  
Total common shares issued     1,684,471  
 

us-gaap:ScheduleOfConversionsOfStockTextBlock